Episode 3: Danielle Drayton, PhD, CEO of REACH Market Research

Episode 3 June 09, 2021 00:39:48
Episode 3: Danielle Drayton, PhD, CEO of REACH Market Research
Few & Far Between: How Biotech Gets Built
Episode 3: Danielle Drayton, PhD, CEO of REACH Market Research

Jun 09 2021 | 00:39:48

/

Show Notes

On today’s podcast, host Wayne Bowden, Vice President of Partnerships and Strategy at Biorasi, will be discussing insights into market research solutions for rare diseases with Danielle Drayton, PhD, CEO of REACH Market Research.

Other Episodes

Episode 37

January 24, 2024 00:41:31
Episode Cover

Episode 37: Will Greene, Prader-Willi Syndrome patient advocate, Healthcare Engagement Lead at Roche

"The history of rare disease drug development indicates that once you start looking harder for cases, you often tend to find them." - Will...

Listen

Episode 45

December 12, 2024 00:37:26
Episode Cover

Episode 46: Dr. Carsten Rudolph, CEO and Managing Director at Ethris

"It's really a very important challenge we had from the very beginning, to see how to stabilize nanoparticles with the messenger RNA so they...

Listen

Episode 16

December 15, 2021 00:58:27
Episode Cover

Episode 16: Dr. Alex Adjei, Scientific Advisory Board Member at Biorasi

Welcome to a special epsiode of Few & Far Between. Our guest this week is oncologist Dr. Alex Adjei, Scientific Advisory Board Member at...

Listen